Specifically, GGCT has been confirmed to activate the PI3K/AKT/mTOR signaling, thereby driving the malignant progression of ovarian cancer, hepatocellular carcinoma, and breast cancer [11,12,13]
Thyroid Cancer: There may be a risk of thyroid cancer, including medullary thyroid carcinoma, for those taking Zepbound
As depicted in Figure 7, we found that there were more TUNEL-positive tubular cells in the FA group, and the number of TUNEL-positive tubular cells in the low-dose and high-dose LA treatment groups was significantly reduced, while there was no particular preference for the higher-dose group
Some may experience mild injection site reactions, temporary water retention, or slight tingling in extremities
I realised it was time to change things, she recalls
Redox Biol 6:344352